NCT06869096 Chlorhexidine Gluconate Versus Saline for Flushing the Surgical Area During Colorectal Cancer Surgery
| NCT ID | NCT06869096 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nanchong Central Hospital |
| Condition | Colorectal Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 532 participants |
| Start Date | 2024-07-02 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 532 participants in total. It began in 2024-07-02 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study was to compare the effectiveness of chlorhexidine versus saline in flushing the surgical area during colorectal cancer surgery. The primary outcomes included surgical site infection, postoperative complication rates, et al.
Eligibility Criteria
Inclusion Criteria: 1. Patients aged 18-85 years, 2. Patients with surgically resectable colorectal tumors confirmed by CT/MRI before surgery 3. All patients had a performance status score of 0 or 1 in the Eastern Tumor Cooperative group 4. American Society of Anesthesiology grade I-III Exclusion Criteria: 1. The tumor may have distant metastasis 2. History of previous abdominal surgery 3. The patient has a history of other malignant tumors diagnosed in the past 5 years and has received radiotherapy and chemotherapy in the past 4. There are obvious contraindications to surgery (obvious abnormal liver and kidney function, pregnancy) 5. Participated in other clinical trials within the past 6 months
Frequently Asked Questions
Who can join the NCT06869096 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Colorectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06869096 currently recruiting?
Yes, NCT06869096 is actively recruiting participants. Visit ClinicalTrials.gov or contact Nanchong Central Hospital to inquire about joining.
Where is the NCT06869096 trial being conducted?
This trial is being conducted at Nanchong, China.
Who is sponsoring the NCT06869096 clinical trial?
NCT06869096 is sponsored by Nanchong Central Hospital. The trial plans to enroll 532 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.